Finally, we also observed that OTX015 treatment strongly affected the architecture of tumor spheroids, which are a source of cancer stem-like cells involved in tumor proliferation, maintenance and spreading, and suppressed CD133 expression, this having a potential impact in overcoming drug resistance mechanisms and so improving the clinical outcome of OC patients. This evidence concerns the gene PROM1 and neoplasm.